The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports
Open accessAbstract
OBJECTIVE: To study serious harms associated with selective serotonin and serotonin-norepinephrine reuptake inhibitors.Design Systematic review and meta-analysis. MAIN OUTCOME MEASURES: Mortality and suicidality. Secondary outcomes were aggressive behaviour and akathisia. DATA SOURCES: Clinical study reports for duloxetine, fluoxetine, paroxetine, sertraline, and venlafaxine obtained from the European and UK drug regulators, and summary trial reports for duloxetine and fluoxetine from Eli Lilly's website. ELIGIBILITY CRITERIA FOR STUDY SELECTION: Double blind placebo controlled trials that contained any patient narratives or individual patient listings of harms. DATA EXTRACTION AND ANALYSIS: Two researchers extracted data independently; the outcomes were meta-analysed by Peto's exact method (fixed effect model). RESULTS: We included 70 trials (64,381 pages of clinical study reports) with 18,526 patients. These trials had limitations in the study design and discrepancies in reporting, which may have led to serious under-reporting of harms. For example, some outcomes appeared only in individual patient listings in appendices, which we had for only 32 trials, and we did not have case report forms for any of the trials. Differences in mortality (all deaths were in adults, odds ratio 1.28, 95% confidence interval 0.40 to 4.06), suicidality (1.21, 0.84 to 1.74), and akathisia (2.04, 0.93 to 4.48) were not significant, whereas patients taking antidepressants displayed more aggressive behaviour (1.93, 1.26 to 2.95). For adults, the odds ratios were 0.81 (0.51 to 1.28) for suicidality, 1.09 (0.55 to 2.14) for aggression, and 2.00 (0.79 to 5.04) for akathisia. The corresponding values for children and adolescents were 2.39 (1.31 to 4.33), 2.79 (1.62 to 4.81), and 2.15 (0.48 to 9.65). In the summary trial reports on Eli Lilly's website, almost all deaths were noted, but all suicidal ideation events were missing, and the information on the remaining outcomes was incomplete. CONCLUSIONS: Because of the shortcomings identified and having only partial access to appendices with no access to case report forms, the harms could not be estimated accurately. In adults there was no significant increase in all four outcomes, but in children and adolescents the risk of suicidality and aggression doubled. To elucidate the harms reliably, access to anonymised individual patient data is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub6 · Cited by 1,834
What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data
J. Sweeting, M., J. Sutton, A., & C. Lambert, P. (2004) · Statistics in Medicine · doi:10.1002/sim.1761 · Cited by 1,734
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.20.1.2 · Cited by 895
Baber, N. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb05705.x · Cited by 759
Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009) · BMJ · doi:10.1136/bmj.b2880 · Cited by 609
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Emergence of intense suicidal preoccupation during fluoxetine treatment
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.207 · Cited by 532
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510
Exercise in prevention and treatment of anxiety and depression among children and young people
Larun, L., Nordheim, L. V., Ekeland, E., Hagen, K. B., & Heian, F. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004691.pub2 · Cited by 492
Gunnell, D., Saperia, J., & Ashby, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.385 · Cited by 387
Active placebos versus antidepressants for depression
Moncrieff, J., Wessely, S., & Hardy, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003012.pub2 · Cited by 342
Le Noury, J., Nardo, J. M., Healy, D., Jureidini, J., Raven, M., Tufanaru, C., & Abi-Jaoude, E. (2015) · BMJ · doi:10.1136/bmj.h4320 · Cited by 329
Violence and Serotonin: Influence of Impulse Control, Affect Regulation, and Social Functioning
KRAKOWSKI, M. I. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.294 · Cited by 239
Leucht, S., Fennema, H., Engel, R., Kaspers–Janssen, M., Lepping, P., & Szegedi, A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.001 · Cited by 211
Driessen, E., Hollon, S. D., Bockting, C. L. H., Cuijpers, P., & Turner, E. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137864 · Cited by 208
Cox, G. R., Callahan, P., Churchill, R., Hunot, V., Merry, S. N., Parker, A. G., & Hetrick, S. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008324.pub3 · Cited by 194
Restoring invisible and abandoned trials: a call for people to publish the findings
Doshi, P., Dickersin, K., Healy, D., Vedula, S. S., & Jefferson, T. (2013) · BMJ · doi:10.1136/bmj.f2865 · Cited by 190
Medicines And Healthcare Products Regulatory Agency
National Cancer Institute (2020) · Definitions · doi:10.32388/7ciy98 · Cited by 166
Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression
Healy, D. (2022) · New York University Press eBooks · doi:10.18574/nyu/9780814790915.001.0001 · Cited by 160
Challenges in Systematic Reviews That Assess Treatment Harms
Chou, R., & Helfand, M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_2-200506211-00009 · Cited by 159
Wieseler, B., Wolfram, N., McGauran, N., Kerekes, M. F., Vervölgyi, V., Kohlepp, P., Kamphuis, M., & Grouven, U. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001526 · Cited by 133
Rosiglitazone: what went wrong?
Cohen, D. (2010) · BMJ · doi:10.1136/bmj.c4848 · Cited by 122
Does long term use of psychiatric drugs cause more harm than good?
Gøtzsche, P. C., Young, A. H., & Crace, J. (2015) · BMJ · doi:10.1136/bmj.h2435 · Cited by 111
Self-citationSelective serotonin reuptake inhibitors and violence: a review of the available evidence
Walsh, M., & Dinan, T. G. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00357.x · Cited by 104
Prescription Drugs Associated with Reports of Violence Towards Others
Moore, T. J., Glenmullen, J., & Furberg, C. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015337 · Cited by 103
Antidepressants and Violence: Problems at the Interface of Medicine and Law
Healy, D., Herxheimer, A., & Menkes, D. B. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030372 · Cited by 102
LAUGHREN, T. P. (2001) · European Psychiatry · doi:10.1016/s0924-9338(01)00600-9 · Cited by 94
Antidepressant dose, age, and the risk of deliberate self-harm
Miller, M., Swanson, S. A., Azrael, D., Pate, V., & Stürmer, T. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1053 · Cited by 92
Maund, E., Tendal, B., Hróbjartsson, A., Jørgensen, K. J., Lundh, A., Schroll, J. B., & Gøtzsche, P. C. (2014) · BMJ · doi:10.1136/bmj.g3510 · Cited by 89
Self-citationBreggin, P. R. (2004) · International Journal of Risk & Safety in Medicine · Cited by 80
Did regulators fail over selective serotonin reuptake inhibitors?
Healy, D. (2006) · BMJ · doi:10.1136/bmj.333.7558.92 · Cited by 79
Weller, I. V. D., Ashby, D., Brook, R., Mga., C., Chick, J., Drummond, C., Ebmeier, K. P., Gunnell, D., Hawking, H., Mukaetova‐Ladinska, E. B., et al. (2005) · Cited by 74
Cox, G. R., Callahan, P., Churchill, R., Hunot, V., Merry, S. N., Parker, A. G., & Hetrick, S. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008324.pub2 · Cited by 70
Deadly Psychiatry and Organised Denial
Gøtzsche, P. C. (2015) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 68
Self-citationSelective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study
Molero, Y., Lichtenstein, P., Zetterqvist, J., Gumpert, C. H., & Fazel, S. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001875 · Cited by 57
Antidepressant treatments and human aggression
Bond, A. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.033 · Cited by 50
Adler, L. A., & ANGRIST, B. M. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00158-y · Cited by 49
Selective serotonin reuptake inhibitor-induced akathisia
Koliscak, L. P., & Makela, E. H. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.08083 · Cited by 48
Akathisia: A review and case report following paroxetine treatment
Baldassano, C. F., Truman, C. J., Nierenberg, A. A., Ghaemi, S. N., & Sachs, G. S. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90572-6 · Cited by 43
Lucire, & Crotty, C. (2011) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s17445 · Cited by 27
Side effects: a prosecutor, a whistleblower, and a bestselling antidepressant on trial
(2008) · Choice Reviews Online · doi:10.5860/choice.46-1510 · Cited by 26
Breggin, P. R. (2001) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2001-253 · Cited by 25
Antidepressants and lethal violence in the Netherlands 1994–2008
Bouvy, P. F., & Liem, M. C. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2668-2 · Cited by 22
All clinical trials must be reported in detail and made publicly available
Furukawa, T. A. (2004) · BMJ · doi:10.1136/bmj.329.7466.626-a · Cited by 13
Cited by
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Chronic Pain and Mental Health Disorders
Hooten, W. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.029 · Cited by 571
Physical Activity and Anxiety: A Systematic Review and Meta-analysis of Prospective Cohort Studies
McDowell, C. P., Dishman, R. K., Gordon, B. R., & Herring, M. P. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.05.012 · Cited by 385
Locher, C., Koechlin, H., Zion, S. R., Werner, C., Pine, D. S., Kirsch, I., Kessler, R. C., & Kossowsky, J. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2432 · Cited by 360
Metadata
- Authors
- Sharma, T., Guski, L. S., Freund, N., & Gøtzsche, P. C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2016-01-27
- Volume
- 352
- Pages
- i65
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2270702517
- Cited by
- 319
- References
- 46
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.